Original Research

Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety

Boudreau GP, Grosberg BM, McAllister PJ, Lipton RB, Buse DC

International Journal of General Medicine 2015, 8:79-86

Published Date: 18 February 2015